Do vaccine adjuvant formulations need to be thermodynamically unstable to increase formulation immunogenicity?
None
Main Author: | Shireesh Apte |
---|---|
Format: | Article |
Language: | English |
Published: |
International Pharmaceutical Excipients Council
|
Series: | Journal of Excipients and Food Chemicals |
Online Access: | http://jefc.scholasticahq.com/article/12262-do-vaccine-adjuvant-formulations-need-to-be-thermodynamically-unstable-to-increase-formulation-immunogenicity.pdf |
Similar Items
-
Immunomodulating Efficacy Of Different Adjuvants In Formulation Of Foot And Mouth Disease Vaccine Relative To Its Immunogenicity
by: El-Sayed, E. I., et al.
Published: (2020-07-01) -
Excipients in formulations for clinical trials: Getting it right the first time
by: Shireesh Apte -
Excipients in formulations for clinical trials: Getting it right the first time
by: Shireesh Apte
Published: (2011-12-01) -
Liposomal formulation of Gp41 derivate with adjuvant MPLA: vaccine design, immunogenicity in animals and safety in humans
by: Katinger D, et al.
Published: (2012-09-01) -
Immunogenicity of two adjuvant formulations of an inactivated African horse sickness vaccine in guinea-pigs and target animals
by: Gaetano Federico Ronchi, et al.
Published: (2012-03-01)